WORLD
Regeneron Pharmaceuticals Said Its COVID-19 Antibody Therapy is Less Effective Against the ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Regeneron Pharmaceuticals said its COVID-19 antibody therapy is less effective against the Omicron variant of the coronavirus, though it is still active against the Delta ...'
Regeneron Pharmaceuticals said its COVID-19 antibody therapy is less effective against the Omicron variant of the coronavirus, though it is still active against the Delta https://t.co/7XUvAGDnBJ— Reuters (@Reuters) December 16, 2021
(The above story first appeared on LatestLY on Dec 16, 2021 06:53 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
